Control of unreasonable growth of medical expenses in public hospitals in Shanghai, China: a multi-agent system model.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
03 Jun 2020
Historique:
received: 12 11 2019
accepted: 07 05 2020
entrez: 5 6 2020
pubmed: 5 6 2020
medline: 15 12 2020
Statut: epublish

Résumé

This study aims to establish a multi-agent system model to provide accurate suggestions for the policy proposal of controlling the unreasonable growth of medical expenses charged by public hospitals in China. A multi-agent system model was employed in this study. Agents of this model were divided into patients, doctors, medical institutions, the government, and medical insurance agencies. The model was composed of two subsystems: the disease and medical-seeking subsystem, and the medical expenses subsystem. Policy intervention experiments were conducted on patients' medical-seeking preferences, doctors' public welfare behaviors, and the government's financial investment. At present, medical expenses in China are unreasonable and keep increasing, and the proportion of medicine and physical examination expenses to total medical expenses for public hospitals is unreasonable. Intervention experiments suggested that expanding the promotion and application of the community first-visit system could rationalize patients' medical-seeking preferences, increasing doctors' incomes and reducing workload could significantly restrict doctors' over-prescription behaviors. Also, improving the government's financial investment could guide public hospitals to strengthen their commitment to public welfare responsibilities. These interventions could decrease the unreasonable growth of medical expenses of public hospitals. The combined intervention effects on suppliers, demanders, and the government were better than the effect of these agents independently. The main reasons for the unreasonable increase in patient medical expenses at public hospitals could be attributed to patients' unreasonable medical-seeking preferences, doctors' weak public welfare incentives, and the government's inadequate financial investment. Policy-makers should consider proposals to restrict and guide the behaviors of suppliers, demanders, and the government, simultaneously. The government should consider the feasibility, response speed, and implementation cost of policies as well.

Sections du résumé

BACKGROUND BACKGROUND
This study aims to establish a multi-agent system model to provide accurate suggestions for the policy proposal of controlling the unreasonable growth of medical expenses charged by public hospitals in China.
METHODS METHODS
A multi-agent system model was employed in this study. Agents of this model were divided into patients, doctors, medical institutions, the government, and medical insurance agencies. The model was composed of two subsystems: the disease and medical-seeking subsystem, and the medical expenses subsystem. Policy intervention experiments were conducted on patients' medical-seeking preferences, doctors' public welfare behaviors, and the government's financial investment.
RESULTS RESULTS
At present, medical expenses in China are unreasonable and keep increasing, and the proportion of medicine and physical examination expenses to total medical expenses for public hospitals is unreasonable. Intervention experiments suggested that expanding the promotion and application of the community first-visit system could rationalize patients' medical-seeking preferences, increasing doctors' incomes and reducing workload could significantly restrict doctors' over-prescription behaviors. Also, improving the government's financial investment could guide public hospitals to strengthen their commitment to public welfare responsibilities. These interventions could decrease the unreasonable growth of medical expenses of public hospitals. The combined intervention effects on suppliers, demanders, and the government were better than the effect of these agents independently.
CONCLUSIONS CONCLUSIONS
The main reasons for the unreasonable increase in patient medical expenses at public hospitals could be attributed to patients' unreasonable medical-seeking preferences, doctors' weak public welfare incentives, and the government's inadequate financial investment. Policy-makers should consider proposals to restrict and guide the behaviors of suppliers, demanders, and the government, simultaneously. The government should consider the feasibility, response speed, and implementation cost of policies as well.

Identifiants

pubmed: 32493382
doi: 10.1186/s12913-020-05309-z
pii: 10.1186/s12913-020-05309-z
pmc: PMC7268700
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

490

Subventions

Organisme : National Natural Science Foundation of China
ID : 71233008
Organisme : National Natural Science Foundation of China
ID : 71774167
Organisme : National Natural Science Foundation of China
ID : 71673291
Organisme : National Natural Science Foundation of China
ID : 71303248
Organisme : Joint Research Project of Major Disease of Shanghai Health System
ID : 2013ZYJB0006
Organisme : Major Project in the '12th Five-Year Plan' of the People's Liberation Army
ID : AWS12J002
Organisme : Shanghai Pujiang Program
ID : 19PJC112

Références

Lancet. 2010 Mar 27;375(9720):1120-30
pubmed: 20346818
Hum Resour Health. 2017 Aug 4;15(1):50
pubmed: 28778199
Lancet. 2012 Mar 3;379(9818):833-42
pubmed: 22386036
PLoS One. 2015 Oct 16;10(10):e0140922
pubmed: 26474161
Hum Resour Health. 2015 May 16;13:34
pubmed: 25975721
Health Econ. 2008 Feb;17(2):149-65
pubmed: 17880024
J Biomed Inform. 2015 Oct;57:399-414
pubmed: 26297984
Soc Sci Med. 2014 Sep;117:134-41
pubmed: 25063969
Int J Health Plann Manage. 2017 Jul;32(3):270-284
pubmed: 28664588
Public Health. 2017 Jun;147:98-100
pubmed: 28404505
BMC Health Serv Res. 2006 Aug 03;6:93
pubmed: 16887022
Wei Sheng Yan Jiu. 2017 Mar;46(2):246-250
pubmed: 29903101
BMJ Open. 2017 Apr 3;7(4):e012565
pubmed: 28373247
Lancet. 2011 Jun 18;377(9783):2064-6
pubmed: 21453962
PLoS One. 2013 Aug 16;8(8):e72166
pubmed: 23977243
Health Policy. 2019 Jan;123(1):71-79
pubmed: 30429060
Health Policy. 2016 May;120(5):486-94
pubmed: 27066728
Lancet. 2011 Aug 6;378(9790):457
pubmed: 21821170
Am J Manag Care. 2009 Dec;15(10 Suppl):S306-21
pubmed: 20088635
BMJ Open. 2017 Nov 1;7(10):e016418
pubmed: 29092898
Health Aff (Millwood). 2007 Jan-Feb;26(1):154-61
pubmed: 17211024
Springerplus. 2016 Nov 4;5(1):1922
pubmed: 27867828
Soc Sci Med. 2009 Jun;68(12):2256-62
pubmed: 19419809
Infect Drug Resist. 2019 Mar 13;12:613-625
pubmed: 30936725
Lancet. 2016 Apr 16;387(10028):1617
pubmed: 27116071

Auteurs

Wenya Yu (W)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Department of Military Health Service Management, College of Military Health Service Management, Second Military Medical University, Shanghai, 200433, China.

Xiang Liu (X)

Department of Respiratory Disease, The 903rd Hospital of PLA, Hangzhou, 310000, Zhejiang, China.

Fangjie Zhao (F)

Department of Military Health Service Management, College of Military Health Service Management, Second Military Medical University, Shanghai, 200433, China.

Meina Li (M)

Department of Military Health Service Management, College of Military Health Service Management, Second Military Medical University, Shanghai, 200433, China. meinali53@sina.cn.

Lulu Zhang (L)

Department of Military Health Service Management, College of Military Health Service Management, Second Military Medical University, Shanghai, 200433, China. zllrmit@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH